CPHI China Pharma Holdings, Inc.

Fundamentals / CIK 0001106644 / USD

China Pharma Holdings, Inc. reported $4.31M in revenue and a net loss of $5.73M for the trailing twelve months ended September 30, 2026 (up 52.5% year over year), with a 14.2% gross margin and a -130.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CPHI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$17.53M$8.77M$0-$20.68MFY 2016 Revenue: $15.57MFY 2016 Net Income: -$9.18M2016FY 2017 Revenue: $13.21MFY 2017 Net Income: -$19.28M2017FY 2018 Revenue: $12.33MFY 2018 Net Income: -$10.75M2018FY 2019 Revenue: $10.92MFY 2019 Net Income: -$20.70M2019FY 2020 Revenue: $10.87MFY 2020 Net Income: -$2.87M2020FY 2021 Revenue: $9.64MFY 2021 Net Income: -$3.40M2021FY 2022 Revenue: $8.10MFY 2022 Net Income: -$3.97M2022FY 2023 Revenue: $7.01MFY 2023 Net Income: -$3.08M2023FY 2024 Revenue: $4.53MFY 2024 Net Income: -$4.74M2024FY 2025 Revenue: $4.14MFY 2025 Net Income: -$3.19M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $4.14M $4.53M $7.01M $8.10M $9.64M $10.87M $10.92M $12.33M $13.21M $15.57M
Cost of Revenue $4.28M $6.51M $7.29M $8.60M $9.29M $8.91M $9.44M $10.36M $10.74M $12.35M
Gross Profit -$132K -$1.99M -$281K -$494K $349K $1.95M $1.48M $1.97M $2.47M $3.22M
Research & Development $281K $284K $240K $186K $319K $378K $230K $172K $90K $366K
Selling, General & Admin $2.83M $2.31M $2.25M $2.96M $3.15M $4.04M $4.64M $5.17M $5.48M $6.30M
Total Operating Expenses $3.11M $2.60M $2.47M $3.06M $3.21M $4.53M $21.89M $12.42M $21.15M $11.72M
Operating Income -$3.24M -$4.59M -$2.75M -$3.55M -$2.86M -$2.58M -$20.41M -$10.45M -$18.68M -$8.16M
EBITDA -$1.74M -$1.97M $1.8K -$848K $227K $101K -$17.48M -$7.19M -$15.39M -$5.08M
Interest Income $2.0K $6.6K $6.6K $11K $3.0K $5.7K $28K $39K $64K $131K
Interest Expense $27K $27K $31K $435K $542K $294K $322K $451K $539K $850K
Income Before Tax -$3.19M -$4.74M -$3.08M -$3.97M -$3.40M -$2.87M -$20.70M -$10.86M -$19.15M -$8.87M
Income Tax Expense -- -- -- -- -- -- -- -$110K $123K $308K
Net Income -$3.19M -$4.74M -$3.08M -$3.97M -$3.40M -$2.87M -$20.70M -$10.75M -$19.28M -$9.18M
Basic EPS -$0.74 -$2.71 -$9.10 -$1,208.23 -$11,826.59 -$1,118.73 -$7,671.30 -$3,995.47 -$7,032.03 -$3,356.19
Diluted EPS -$0.74 -$2.71 -$9.10 -$1,208.23 -$11,826.59 -$1,118.73 -$7,671.30 -$3,995.47 -$7,032.03 -$3,356.19
Basic Shares Outstanding 4.3M 1.7M 338.4K 3.3K 289 2.7K 2.7K 2.7K 2.7K 2.7K
Diluted Shares Outstanding -- -- -- -- 2.9K 2.7K 2.7K 2.7K 2.7K 2.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.15M $948K $984K $1.23M $756K $1.03M $1.14M $1.13M
Cost of Revenue $1.06M $865K $698K $1.08M $816K $1.11M $1.27M $1.29M
Gross Profit $92K $84K $285K $151K -$60K -$87K -$136K -$161K
Research & Development $16K $19K $84K $190K $40K $21K $30K $547
Selling, General & Admin $1.45M $1.49M $1.32M $1.19M $503K $542K $594K $1.03M
Total Operating Expenses $1.97M $1.52M $1.40M $1.35M $568K $565K $623K $1.04M
Operating Income -$1.88M -$1.43M -$1.12M -$1.20M -$628K -$652K -$759K -$1.20M
EBITDA -$753K -$330K -$137K -$703K -$272K -$331K -$429K -$748K
Interest Income $2.2K $81 $147 $213 $294 $422 $1.1K $1.3K
Interest Expense $10K $9.3K $9.1K $6.9K $6.8K $6.8K $6.8K $6.8K
Income Before Tax -$1.90M -$1.46M -$1.14M -$1.22M -$651K -$528K -$786K -$1.22M
Net Income -$1.90M -$1.46M -$1.14M -$1.22M -$651K -$528K -$786K -$1.22M
Basic EPS -$0.04 -$0.04 -$0.04 -- -$0.17 -$0.16 -$0.24 --
Diluted EPS -$0.04 -$0.04 -$0.04 -- -$0.17 -$0.16 -$0.24 --
Basic Shares Outstanding 42.4M 40.5M 25.6M -- 3.9M 3.2M 3.3M --
Diluted Shares Outstanding 42.4M 40.5M 25.6M -- 3.9M 3.2M 3.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $345K $627K $1.42M $2.03M $4.86M $958K $1.07M $1.19M $2.03M $2.67M
Cash & Short-Term Investments $345K $627K $1.42M $2.03M $4.86M $958K $1.07M $1.19M $2.03M $2.67M
Accounts Receivable, Net $241K $232K $504K $422K -- $502K $635K $917K $2.29M $4.00M
Inventory $1.62M $2.27M $3.73M $2.95M $2.95M $3.71M $3.59M $5.05M $6.41M $7.31M
Total Current Assets $2.35M $3.27M $6.00M $5.96M $9.09M $5.32M $5.58M $8.75M $12.29M $17.52M
Property, Plant & Equipment, Net $4.39M $4.88M $7.10M $9.97M $13.28M $15.56M $16.31M $19.29M $23.54M $24.97M
Intangible Assets $24.08M $6.70M $3.26M $1.81M $148K $182K $206K $266K $399K $535K
Total Non-Current Assets $28.65M $11.62M $10.47M $11.82M $13.56M $15.80M $16.66M $36.63M $47.66M $61.00M
Total Assets $31.00M $14.89M $16.47M $17.78M $22.65M $21.12M $22.24M $45.38M $59.95M $78.52M
Accounts Payable $891K $225K $966K $667K $927K $1.23M $1.37M $1.06M $1.14M $3.06M
Short-Term Debt $1.44M $1.14M $1.13M -- -- -- -- -- -- --
Deferred Revenue (Current) $112K $162K $91K $520K $210K $720K $505K -- -- --
Other Current Liabilities -- -- -- $2.48M $2.78M $2.13M $2.07M -- -- --
Total Current Liabilities $7.40M $5.02M $6.82M $12.74M $10.51M $11.40M $10.05M $10.05M $9.23M $10.40M
Long-Term Debt -- -- -- -- -- $5.24M $4.30M $6.54M $9.22M --
Total Non-Current Liabilities $859K $2.12M $2.19M $755K $6.12M $1.71M $2.95M $5.13M $7.65M $9.21M
Total Liabilities $8.26M $7.14M $9.01M $13.49M $16.63M $13.11M $13.00M $15.18M $16.88M $19.61M
Total Debt (incl. Leases) $1.62M $1.18M $1.25M $40K $85K $5.29M $4.44M $6.54M $9.22M --
Common Stock $16K $3.3K $11K $1.5K $47K $46K $44K $44K $44K $44K
Retained Earnings -$47.21M -$44.03M -$39.29M -$36.21M -$32.24M -$28.84M -$25.97M -$5.27M $5.48M $24.76M
Accumulated Other Comp. Income $11.58M $11.32M $11.45M $11.57M $12.56M $12.35M $11.58M $11.84M $13.96M $10.52M
Total Stockholders' Equity $22.74M $7.75M $7.45M $4.29M $6.02M $8.00M $9.24M $30.20M $43.07M $58.91M
Total Equity $22.74M $7.75M $7.45M $4.29M $6.02M $8.00M $9.24M $30.20M $43.07M $58.91M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $3.68M $305K $168K $345K $268K $600K $400K $627K
Cash & Short-Term Investments $3.68M $305K $168K $345K $268K $600K $400K $627K
Accounts Receivable, Net $197K $182K $196K $241K $225K $269K $329K $232K
Inventory $1.32M $1.36M $1.50M $1.62M $1.65M $1.68M $1.98M $2.27M
Total Current Assets $5.39M $2.01M $2.00M $2.35M $2.33M $2.70M $2.85M $3.27M
Property, Plant & Equipment, Net $4.12M $4.22M $4.30M $4.39M $4.50M $4.63M $4.78M $4.88M
Intangible Assets $37.30M $38.34M $38.67M $24.08M $8.78M $6.44M $6.57M $6.70M
Total Non-Current Assets $41.54M $42.70M $43.14M $28.65M $13.48M $11.07M $11.37M $11.62M
Total Assets $46.93M $44.71M $45.14M $31.00M $15.80M $13.77M $14.22M $14.89M
Accounts Payable $304K $734K $837K $891K $589K $531K $548K $225K
Short-Term Debt $1.57M $1.64M $1.47M $1.44M $1.41M $1.41M $1.15M $1.14M
Deferred Revenue (Current) $48K $154K $62K $112K $121K $78K $114K $162K
Total Current Liabilities $7.03M $7.68M $7.27M $7.40M $6.62M $5.25M $5.12M $5.02M
Total Non-Current Liabilities $838K $847K $852K $859K $868K $2.05M $2.13M $2.12M
Total Liabilities $7.86M $8.53M $8.12M $8.26M $7.49M $7.30M $7.25M $7.14M
Total Debt (incl. Leases) $1.70M $1.79M $1.63M $1.62M $1.61M $1.41M $1.17M $1.18M
Common Stock $43K $41K $41K $16K $5.0K $3.3K $3.3K $3.3K
Retained Earnings -$51.72M -$49.82M -$48.36M -$47.21M -$45.99M -$45.34M -$44.81M -$44.03M
Accumulated Other Comp. Income $13.04M $12.63M $12.02M $11.58M $11.40M $11.35M $11.33M $11.32M
Total Stockholders' Equity $39.07M $36.18M $37.02M $22.74M $8.31M $6.46M $6.97M $7.75M
Total Equity $39.07M $36.18M $37.02M $22.74M $8.31M $6.46M $6.97M $7.75M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$3.19M -$4.74M -$3.08M -$3.97M -$3.40M -$2.87M -$20.70M -$10.75M -$19.28M -$9.18M
Depreciation & Amortization $1.50M $2.62M $2.75M $2.70M $3.09M $2.68M $2.93M $3.26M $3.29M $3.08M
Change in Receivables -$13.88M $0 $0 $0 $0 -$688K $0 $0 $0 -$13.50M
Change in Inventory $590K $1.61M -$17K $689K $1.01M $808K $2.00M $689K $1.72M $2.73M
Change in Payables $650K -$734K $312K -$188K -$333K -$214K $324K -$16K -$2.05M $815K
Operating Cash Flow $148K -$406K -$700K -$410K -$250K -$42K $608K $1.88M $841K $2.90M
Capital Expenditure -$59K -$38K -$12K -$402K -$438K -$867K -$136K -$51K -$136K -$193K
Free Cash Flow $89K -$444K -$711K -$812K -$688K -$910K $472K $1.83M $705K $2.70M
Investing Cash Flow -$137K -$292K -$12K -$402K -$438K -$867K -$136K -$51K -$136K -$193K
Financing Cash Flow -$294K -$34K $73K -$1.77M $4.60M $624K -$1.73M -$1.98M -$1.48M -$6.02M
Net Change in Cash -$282K -$797K -$606K -$2.83M $3.90M -$227K -$1.28M -$279K -$636K -$3.58M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.90M -$1.46M -$1.14M -$1.22M -$651K -$528K -$786K -$1.22M
Depreciation & Amortization $1.12M $1.10M $981K $497K $356K $321K $329K $448K
Stock-Based Compensation -- $0 $0 -- -- $0 -- --
Change in Inventory $17K $273K $247K $211K $58K $165K $157K $511K
Change in Payables -$431K -$116K -$68K $292K $54K -$19K $323K -$156K
Operating Cash Flow -$1.11M -$33K -$55K $152K -$204K $274K -$74K $299K
Capital Expenditure -- -- -- -$454 -$611 $65 -$58K --
Free Cash Flow -- -- -- $152K -$205K $274K -$132K --
Investing Cash Flow -- -- -- -$5.8K -$73K $65 -$58K --
Financing Cash Flow $4.50M $120K -$79K -$73K -$122K -$22K -$77K -$54K
Net Change in Cash $3.38M $136K -$177K $77K -$357K $212K -$214K -$92K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -3.2% -43.8% -4.0% -6.1% 3.6% 18.0% 13.6% 16.0% 18.7% 20.7%
Operating Margin -78.2% -101.3% -39.2% -43.8% -29.7% -23.7% -186.8% -84.7% -141.4% -52.4%
Net Profit Margin -76.9% -104.6% -43.9% -49.0% -35.3% -26.4% -189.5% -87.2% -145.9% -59.0%
Return on Equity (ROE) -14.0% -61.1% -41.3% -92.6% -56.5% -35.8% -224.1% -35.6% -44.8% -15.6%
Return on Assets (ROA) -10.3% -31.8% -18.7% -22.3% -15.0% -13.6% -93.1% -23.7% -32.2% -11.7%
Current Ratio 0.32x 0.65x 0.88x 0.47x 0.86x 0.47x 0.56x 0.87x 1.33x 1.68x
Quick Ratio 0.10x 0.20x 0.33x 0.24x 0.58x 0.14x 0.20x 0.37x 0.64x 0.98x
Debt to Equity 0.07x 0.15x 0.17x 0.01x 0.01x 0.66x 0.48x 0.22x 0.21x --
Revenue Growth (YoY) -8.5% -35.4% -13.5% -15.9% -11.3% -0.5% -11.4% -6.7% -15.1% -23.5%
Gross Profit Growth (YoY) -- -- -- -241.4% -82.1% +31.8% -24.9% -20.0% -23.3% +119.8%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -106.9% -67.7% +123.7% -70.9% -13.6%
Free Cash Flow Growth (YoY) -- -- -- -- -- -292.6% -74.2% +159.8% -73.9% -33.0%
5Y Revenue / Share Growth -100.0% -99.9% -99.5% -49.1% +484.3% -46.7% -50.6% -- -- --
10Y Revenue / Share Growth -100.0% -100.0% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 14.2% 11.8% 7.3% -3.2% -10.9% -20.5% -42.6% -43.8%
Operating Margin -130.5% -111.8% -90.1% -78.2% -79.8% -84.0% -103.2% -101.3%
Net Profit Margin -132.8% -114.3% -88.8% -76.9% -78.7% -83.2% -106.3% -104.6%
Return on Equity (ROE) -14.7% -12.4% -9.6% -14.0% -38.4% -56.6% -65.5% -61.1%
Return on Assets (ROA) -12.2% -10.0% -7.9% -10.3% -20.2% -26.6% -32.1% -31.8%
Current Ratio 0.77x 0.26x 0.28x 0.32x 0.35x 0.51x 0.56x 0.65x
Quick Ratio 0.58x 0.08x 0.07x 0.10x 0.10x 0.19x 0.17x 0.20x
Debt to Equity 0.04x 0.05x 0.04x 0.07x 0.19x 0.22x 0.17x 0.15x
Revenue Growth (YoY) +52.5% -7.5% -13.4% +8.1% -31.3% +10.9% -17.0% -47.2%
Operating Cash Flow Growth (YoY) -- -112.0% -- -49.1% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001106644) · from September 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:03 UTC · Open in terminal